Quintiles, the world’s largest life science services company, is adding another honor. After being named to the Fortune 500 earlier this week, Quintiles on Friday was selected for the CIO 100 list for information technology innovation.

Driving the recognition for Quintiles (NYSE: Q) was its four-year-old program known as Infosario Safety. Infosario is designed to improve drug safety and is linked to regulatory agencies as well as continuous patient reporting. 

“We are honored to be included in the CIO 100 for our work in helping to solve industry and customer challenges,” said Quintiles CIO Richard Thomas. “Introduced in 2011, our award-winning Infosario solutions combine our deep scientific and operational expertise with industry-leading technology innovations that improve our customers’ probability of success at every step of the way.

“We take tremendous pride in this recognition, but what really drives us is our passion to help patients,” he added in a statement. “Patient safety is a top priority for us, just as it is for our customers. Infosario Safety helps conquer some of the complexity involved in safeguarding patients. We believe technology innovation must be focused on success in human measures.”


More Quntiles coverage from WRAL TechWire:

  • Quintiles cracks Fortune 500{//a}}
  • Inside Quintiles’ latest acquisition
  • Quintiles buys helth informatin analytics firm

QUINTILES ARCHIVE: Check out more than a decade of Quintiles stories as reported in WRALTechWire.


“For 27 years now, the CIO 100 awards have honored the innovative use of technology to deliver genuine business value,” said Maryfran Johnson, editor in chief of CIO magazine and events. “Our 2014 winners are an outstanding example of the transformative power of IT to drive everything from revenue growth to competitive advantage.”

The honor is one of several Quintiles has received for IT innovation.

A year ago, Quintiles received Computerworld Data+ Editor’s Choice Award for its Infosario platform and efforts to create big data solutions to help pharmaceutical organizations improve drug development.

Last fall, Quintiles made the InformationWeek 500 for the fifth consecutive year.

Infosario is linked to more than 35 drug safety systems. Information is updated continuously. 

Quintiles says the program offers:

  • Massive cost reductions versus legacy solutions;
  • Automated regulatory agency and partner integration;
  • Guaranteed information exchange;
  • Comprehensive safety capabilities and best-of-breed processes;
  • Enhanced regulatory and operational reporting capabilities;
  • Enhanced compliance;
  • Secure environment, guaranteeing patient privacy and pharma confidentiality.